Use of Non-Invasive Ventilation in Children and Ad... - BV FAPESP
Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Use of Non-Invasive Ventilation in Children and Adolescents: Scientific Evidence

Full text
Author(s):
Goncalves Bonaldo, Taisa Crespi [1] ; Souza Gomez, Carla Cristina [1] ; Francisco Parazzi, Paloma Lopes [1] ; Bresciani Almeida, Celize Cruz [1] ; Lima Marson, Fernando Augusto [1, 2] ; de Oliveira, Therezinha [1] ; Alves Grande, Rosangela Aparecida [1] ; Cohen, Milena Antonelli [1]
Total Authors: 8
Affiliation:
[1] Univ Estadual Campinas, Dept Pediat, Tessalia Vieira de Camargo 126, BR-13083887 Sao Paulo - Brazil
[2] Univ Estadual Campinas, Dept Med Genet, Tessalia Vieira de Camargo 126, BR-13083887 Sao Paulo - Brazil
Total Affiliations: 2
Document type: Review article
Source: CURRENT RESPIRATORY MEDICINE REVIEWS; v. 13, n. 2, p. 82-92, 2017.
Web of Science Citations: 0
Abstract

Background: Noninvasive ventilation (NIV) is a method of positive pressure ventilation that does not require an endotracheal tube. NIV is used in pediatrics in numerous clinical conditions, but it is necessary to systematize the available knowledge to better understand its application and effectiveness in disease management. Objective: To discuss the scientific evidence published in the last five years (2011 to 2016) regarding the use of NIV in children and adolescents. Methods: A systematic review was performed in the databases PEDro and MEDLINE using the descriptors: noninvasive ventilation, pediatrics, children and adolescent. We selected articles with participants aged from zero to 20 years, regardless of pathology, who were submitted to NIV in the hospital or at home. We excluded studies that did not have the assessment of NIV as the main objective. Results: Initially, 377 articles were identified, of these, 123 articles were excluded because of the title, year or duplicity, 147 because of the abstract, and 73 after full reading. Thus, 34 articles were included in the review. Of the 34 articles evaluated, only two reported side effects for NIV, but the benefits outweigh the side effects mentioned. Conclusion: NIV has become a reality well established and studied in pediatrics in numerous diseases. In the review, we demonstrated that NIV is safe, viable and effective for the treatment of acute respiratory failure, obstructive sleep apnea syndrome, nocturnal alveolar hypoventilation, acute viral bronchiolitis, neuromuscular disease, asthma and cystic fibrosis, and that it can be used as therapy at home. (AU)

FAPESP's process: 11/12939-4 - Association between polymorphisms in modifier genes in children and adolescent with allergic and non-allergic: mild, moderate and severe asthma
Grantee:Fernando Augusto de Lima Marson
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 15/12183-8 - Identification of prevalent mutations and clinical and functional characterization of children and adults with primary ciliary dyskinesia
Grantee:Jose Dirceu Ribeiro
Support Opportunities: Regular Research Grants
FAPESP's process: 11/18845-1 - Association between polymorphisms in modifier genes in children and adolescent with allergic and non-allergic mild, moderate and severe asthma
Grantee:Jose Dirceu Ribeiro
Support Opportunities: Regular Research Grants
FAPESP's process: 15/12858-5 - Identification of prevalent mutations and clinical and functional characterization of children and adults with primary ciliary dyskinesia
Grantee:Fernando Augusto de Lima Marson
Support Opportunities: Scholarships in Brazil - Post-Doctoral